Journal
THERAPEUTICS AND CLINICAL RISK MANAGEMENT
Volume 17, Issue -, Pages 989-999Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/TCRM.S269336
Keywords
chloroquine; G6PD; hypnozoite; primaquine; relapse; WR238605
Categories
Ask authors/readers for more resources
This article serves as a brief guide on potential adverse events associated with tafenoquine (TQ) intake, summarizing safety and efficacy findings in Plasmodium vivax malaria prophylaxis and radical cure, and highlighting recent TQ-related studies. It also delves into lesser-known biological and other aspects of malaria parasites and 8-aminoquinoline (8-AQ) drug action, while providing explanations on relevant terminology in the field of malaria.
This article is inter alia a brief, first-stop guide to possible adverse events (AEs) associated with tafenoquine (TQ) intake. Safety and efficacy findings for TQ in Plasmodium vivax malaria prophylaxis and radical cure are summarized and some of the latest TQ-related studies (published in 2020 and 2021) are highlighted. In addition, little-known biological and other matters concerning malaria parasites and 8-aminoquinoline (8-AQ) drug action are discussed and some correct terminology pertinent to malaria is explained.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available